ID   ANPRA_HUMAN             Reviewed;        1061 AA.
AC   P16066; B0ZBF0; Q5SR08; Q6P4Q3;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   12-OCT-2022, entry version 220.
DE   RecName: Full=Atrial natriuretic peptide receptor 1 {ECO:0000305};
DE            EC=4.6.1.2 {ECO:0000269|PubMed:1672777};
DE   AltName: Full=Atrial natriuretic peptide receptor type A;
DE            Short=ANP-A;
DE            Short=ANPR-A;
DE            Short=NPR-A;
DE   AltName: Full=Guanylate cyclase A;
DE            Short=GC-A;
DE   Flags: Precursor;
GN   Name=NPR1 {ECO:0000312|HGNC:HGNC:7943}; Synonyms=ANPRA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=2569967; DOI=10.1002/j.1460-2075.1989.tb03518.x;
RA   Lowe D.G., Chang M.S., Hellmiss R., Chen E., Singh S., Garbers D.L.,
RA   Goeddel D.V.;
RT   "Human atrial natriuretic peptide receptor defines a new paradigm for
RT   second messenger signal transduction.";
RL   EMBO J. 8:1377-1384(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   PubMed=9618281; DOI=10.1006/bbrc.1998.8693;
RA   Takahashi Y., Nakayama T., Soma M., Izumi Y., Kanmatsuse K.;
RT   "Organization of the human natriuretic peptide receptor A gene.";
RL   Biochem. Biophys. Res. Commun. 246:736-739(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Maeda N., Knowles J.W.;
RT   "Identification of functional polymorphisms in noncoding regions of the
RT   human natriuretic peptide receptor A gene.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 634-1048.
RC   TISSUE=Retina;
RX   PubMed=7954658; DOI=10.1007/bf02088585;
RA   Pardhasaradhi K., Kutty R.K., Gentleman S., Krishna G.;
RT   "Expression of mRNA for atrial natriuretic peptide receptor guanylate
RT   cyclase (ANPRA) in human retina.";
RL   Cell. Mol. Neurobiol. 14:1-7(1994).
RN   [9]
RP   LIGAND-BINDING.
RX   PubMed=1660465; DOI=10.1016/s0021-9258(18)54463-x;
RA   Bennett B.D., Bennett G.L., Vitangcol R.V., Jewett J.R., Burnier J.,
RA   Henzel W., Lowe D.G.;
RT   "Extracellular domain-IgG fusion proteins for three human natriuretic
RT   peptide receptors. Hormone pharmacology and application to solid phase
RT   screening of synthetic peptide antisera.";
RL   J. Biol. Chem. 266:23060-23067(1991).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=1672777; DOI=10.1126/science.1672777;
RA   Koller K.J., Lowe D.G., Bennett G.L., Minamino N., Kangawa K., Matsuo H.,
RA   Goeddel D.V.;
RT   "Selective activation of the B natriuretic peptide receptor by C-type
RT   natriuretic peptide (CNP).";
RL   Science 252:120-123(1991).
RN   [11]
RP   PHOSPHORYLATION AT SER-519; SER-529; THR-532; SER-534 AND SER-538.
RX   PubMed=20977274; DOI=10.1021/bi101700e;
RA   Yoder A.R., Stone M.D., Griffin T.J., Potter L.R.;
RT   "Mass spectrometric identification of phosphorylation sites in guanylyl
RT   cyclase A and B.";
RL   Biochemistry 49:10137-10145(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-182; CYS-270; MET-755; GLN-939 AND
RP   LYS-967.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for the atrial natriuretic peptide NPPA/ANP and the
CC       brain natriuretic peptide NPPB/BNP which are potent vasoactive hormones
CC       playing a key role in cardiovascular homeostasis. Has guanylate cyclase
CC       activity upon binding of the ligand. {ECO:0000269|PubMed:1672777}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP = 3',5'-cyclic GMP + diphosphate; Xref=Rhea:RHEA:13665,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:37565, ChEBI:CHEBI:57746; EC=4.6.1.2;
CC         Evidence={ECO:0000269|PubMed:1672777};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13666;
CC         Evidence={ECO:0000305|PubMed:1672777};
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- PTM: Phosphorylation of the protein kinase-like domain is required for
CC       full activation by ANP. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl cyclase
CC       family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X15357; CAA33417.1; -; mRNA.
DR   EMBL; AB010491; BAA31199.1; -; Genomic_DNA.
DR   EMBL; AF190631; AAF01340.1; -; Genomic_DNA.
DR   EMBL; EU326310; ACA05918.1; -; Genomic_DNA.
DR   EMBL; AL713889; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53284.1; -; Genomic_DNA.
DR   EMBL; BC063304; AAH63304.1; -; mRNA.
DR   EMBL; S72628; AAD14112.1; -; mRNA.
DR   CCDS; CCDS1051.1; -.
DR   PIR; S04459; OYHUAR.
DR   RefSeq; NP_000897.3; NM_000906.3.
DR   AlphaFoldDB; P16066; -.
DR   SMR; P16066; -.
DR   BioGRID; 110941; 12.
DR   ComplexPortal; CPX-35; ANPR-A receptor complex.
DR   DIP; DIP-46246N; -.
DR   IntAct; P16066; 5.
DR   MINT; P16066; -.
DR   STRING; 9606.ENSP00000357669; -.
DR   BindingDB; P16066; -.
DR   ChEMBL; CHEMBL1988; -.
DR   DrugBank; DB01612; Amyl Nitrite.
DR   DrugBank; DB01613; Erythrityl tetranitrate.
DR   DrugBank; DB00883; Isosorbide dinitrate.
DR   DrugBank; DB04899; Nesiritide.
DR   DrugBank; DB00727; Nitroglycerin.
DR   DrugBank; DB00325; Nitroprusside.
DR   DrugBank; DB05034; Ularitide.
DR   DrugCentral; P16066; -.
DR   GuidetoPHARMACOLOGY; 1747; -.
DR   TCDB; 8.A.85.1.6; the guanylate cyclase (gc) family.
DR   GlyGen; P16066; 7 sites.
DR   iPTMnet; P16066; -.
DR   PhosphoSitePlus; P16066; -.
DR   BioMuta; NPR1; -.
DR   DMDM; 113912; -.
DR   EPD; P16066; -.
DR   jPOST; P16066; -.
DR   MassIVE; P16066; -.
DR   MaxQB; P16066; -.
DR   PaxDb; P16066; -.
DR   PeptideAtlas; P16066; -.
DR   PRIDE; P16066; -.
DR   ProteomicsDB; 53265; -.
DR   ABCD; P16066; 1 sequenced antibody.
DR   Antibodypedia; 20386; 316 antibodies from 31 providers.
DR   DNASU; 4881; -.
DR   Ensembl; ENST00000368680.4; ENSP00000357669.3; ENSG00000169418.10.
DR   GeneID; 4881; -.
DR   KEGG; hsa:4881; -.
DR   MANE-Select; ENST00000368680.4; ENSP00000357669.3; NM_000906.4; NP_000897.3.
DR   UCSC; uc001fcs.5; human.
DR   CTD; 4881; -.
DR   DisGeNET; 4881; -.
DR   GeneCards; NPR1; -.
DR   HGNC; HGNC:7943; NPR1.
DR   HPA; ENSG00000169418; Tissue enhanced (adipose).
DR   MIM; 108960; gene.
DR   neXtProt; NX_P16066; -.
DR   OpenTargets; ENSG00000169418; -.
DR   PharmGKB; PA31736; -.
DR   VEuPathDB; HostDB:ENSG00000169418; -.
DR   eggNOG; KOG1023; Eukaryota.
DR   GeneTree; ENSGT00940000156223; -.
DR   HOGENOM; CLU_001072_1_3_1; -.
DR   InParanoid; P16066; -.
DR   OMA; KCAYEKS; -.
DR   OrthoDB; 229634at2759; -.
DR   PhylomeDB; P16066; -.
DR   TreeFam; TF106338; -.
DR   BRENDA; 4.6.1.2; 2681.
DR   PathwayCommons; P16066; -.
DR   Reactome; R-HSA-5578768; Physiological factors.
DR   SignaLink; P16066; -.
DR   SIGNOR; P16066; -.
DR   BioGRID-ORCS; 4881; 17 hits in 1104 CRISPR screens.
DR   ChiTaRS; NPR1; human.
DR   GeneWiki; NPR1; -.
DR   GenomeRNAi; 4881; -.
DR   Pharos; P16066; Tclin.
DR   PRO; PR:P16066; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P16066; protein.
DR   Bgee; ENSG00000169418; Expressed in descending thoracic aorta and 174 other tissues.
DR   ExpressionAtlas; P16066; baseline and differential.
DR   Genevisible; P16066; HS.
DR   GO; GO:1990620; C:ANPR-A receptor complex; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0008528; F:G protein-coupled peptide receptor activity; NAS:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IDA:UniProtKB.
DR   GO; GO:0042562; F:hormone binding; IPI:UniProtKB.
DR   GO; GO:0016941; F:natriuretic peptide receptor activity; IDA:UniProtKB.
DR   GO; GO:0017046; F:peptide hormone binding; IPI:UniProtKB.
DR   GO; GO:0001653; F:peptide receptor activity; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0097746; P:blood vessel diameter maintenance; NAS:UniProtKB.
DR   GO; GO:0007589; P:body fluid secretion; TAS:UniProtKB.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IDA:GO_Central.
DR   GO; GO:0019934; P:cGMP-mediated signaling; IEA:Ensembl.
DR   GO; GO:0042417; P:dopamine metabolic process; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; TAS:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0010753; P:positive regulation of cGMP-mediated signaling; IEA:Ensembl.
DR   GO; GO:0035815; P:positive regulation of renal sodium excretion; TAS:UniProtKB.
DR   GO; GO:0035810; P:positive regulation of urine volume; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0007168; P:receptor guanylyl cyclase signaling pathway; IDA:UniProtKB.
DR   GO; GO:0008217; P:regulation of blood pressure; NAS:UniProtKB.
DR   GO; GO:0043114; P:regulation of vascular permeability; TAS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   CDD; cd07302; CHD; 1.
DR   Gene3D; 3.30.70.1230; -; 1.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001170; ANPR/GUC.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00211; Guanylate_cyc; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PRINTS; PR00255; NATPEPTIDER.
DR   SMART; SM00044; CYCc; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
DR   SUPFAM; SSF55073; SSF55073; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00458; ANF_RECEPTORS; 1.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   cGMP biosynthesis; Chloride; Disulfide bond; Glycoprotein; GTP-binding;
KW   Lyase; Membrane; Nucleotide-binding; Phosphoprotein; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix; Vasoactive.
FT   SIGNAL          1..32
FT   CHAIN           33..1061
FT                   /note="Atrial natriuretic peptide receptor 1"
FT                   /id="PRO_0000012360"
FT   TOPO_DOM        33..473
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        474..494
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        495..1061
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          528..805
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          876..1006
FT                   /note="Guanylate cyclase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         85
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000250"
FT   BINDING         117
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000250"
FT   BINDING         118
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         519
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20977274"
FT   MOD_RES         529
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20977274"
FT   MOD_RES         532
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:20977274"
FT   MOD_RES         534
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20977274"
FT   MOD_RES         538
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20977274"
FT   MOD_RES         542
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P18910"
FT   MOD_RES         545
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P18910"
FT   CARBOHYD        34
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        45
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        212
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        338
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        379
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        386
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        427
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        92..118
FT                   /evidence="ECO:0000250"
FT   DISULFID        196..245
FT                   /evidence="ECO:0000250"
FT   DISULFID        455..464
FT                   /evidence="ECO:0000250"
FT   VARIANT         182
FT                   /note="A -> V (in dbSNP:rs56019647)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042214"
FT   VARIANT         270
FT                   /note="F -> C (in a breast pleomorphic lobular carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042215"
FT   VARIANT         755
FT                   /note="V -> M (in dbSNP:rs55837780)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042216"
FT   VARIANT         939
FT                   /note="R -> Q (in dbSNP:rs35240348)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042217"
FT   VARIANT         967
FT                   /note="E -> K (in dbSNP:rs35479618)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042218"
FT   CONFLICT        344
FT                   /note="G -> V (in Ref. 7; AAH63304)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1061 AA;  118919 MW;  E6B5BD0FCA32F70D CRC64;
     MPGPRRPAGS RLRLLLLLLL PPLLLLLRGS HAGNLTVAVV LPLANTSYPW SWARVGPAVE
     LALAQVKARP DLLPGWTVRT VLGSSENALG VCSDTAAPLA AVDLKWEHNP AVFLGPGCVY
     AAAPVGRFTA HWRVPLLTAG APALGFGVKD EYALTTRAGP SYAKLGDFVA ALHRRLGWER
     QALMLYAYRP GDEEHCFFLV EGLFMRVRDR LNITVDHLEF AEDDLSHYTR LLRTMPRKGR
     VIYICSSPDA FRTLMLLALE AGLCGEDYVF FHLDIFGQSL QGGQGPAPRR PWERGDGQDV
     SARQAFQAAK IITYKDPDNP EYLEFLKQLK HLAYEQFNFT MEDGLVNTIP ASFHDGLLLY
     IQAVTETLAH GGTVTDGENI TQRMWNRSFQ GVTGYLKIDS SGDRETDFSL WDMDPENGAF
     RVVLNYNGTS QELVAVSGRK LNWPLGYPPP DIPKCGFDNE DPACNQDHLS TLEVLALVGS
     LSLLGILIVS FFIYRKMQLE KELASELWRV RWEDVEPSSL ERHLRSAGSR LTLSGRGSNY
     GSLLTTEGQF QVFAKTAYYK GNLVAVKRVN RKRIELTRKV LFELKHMRDV QNEHLTRFVG
     ACTDPPNICI LTEYCPRGSL QDILENESIT LDWMFRYSLT NDIVKGMLFL HNGAICSHGN
     LKSSNCVVDG RFVLKITDYG LESFRDLDPE QGHTVYAKKL WTAPELLRMA SPPVRGSQAG
     DVYSFGIILQ EIALRSGVFH VEGLDLSPKE IIERVTRGEQ PPFRPSLALQ SHLEELGLLM
     QRCWAEDPQE RPPFQQIRLT LRKFNRENSS NILDNLLSRM EQYANNLEEL VEERTQAYLE
     EKRKAEALLY QILPHSVAEQ LKRGETVQAE AFDSVTIYFS DIVGFTALSA ESTPMQVVTL
     LNDLYTCFDA VIDNFDVYKV ETIGDAYMVV SGLPVRNGRL HACEVARMAL ALLDAVRSFR
     IRHRPQEQLR LRIGIHTGPV CAGVVGLKMP RYCLFGDTVN TASRMESNGE ALKIHLSSET
     KAVLEEFGGF ELELRGDVEM KGKGKVRTYW LLGERGSSTR G
//
